Our Journey
We are specialists in global health “delivery.” Particularly in resource-limited settings where infectious disease is prevalent, we help:
ADHERENCE
Patients take their life-saving medications as prescribed.
ACCESS
Make life-saving medications more affordable and more available to patients and places that need them.
SCALE
Bring innovative technologies, systems, and processes to market at scale to enhance, re-imagine, or reinvent patient care and improve lives.
For more than a decade, we have developed approaches to address these challenges. One of our earliest and most impactful engagements was helping Walmart implement its $4 Generic program to bring approximately 250 individual medications to US patients – 300 million prescriptions annually, each at $4, and each in an adherence-enhancing package. Our team was responsible for helping reinvent Walmart’s global pharmaceutical supply chain to deliver this massive, access-enhancing program.
Although we now work mostly in global health, in many instances we apply strategies that have been successful time and again in the private sector to bring new products and services to consumers – with incredible speed and at massive scale. From an innovation and delivery perspective, global health is just not that different. In global health, we leverage our experience and expertise to help reduce the time to implementation for essential innovations and to massively accelerate scale-up.
The tactics and tools we use are as varied as the problems we solve. Recently, we’ve successfully resolved delivery challenges by:
Accelerating innovation uptake by facilitating engagement with global health partners and potential funders.
Advising on approaches for radically driving down the cost and timelines of product development.
Introducing a systematic process to identify and address country-specific barriers to uptake or scale.
Supporting advocacy and global policy efforts that make a case for change.
Facilitating patient and provider acceptance through user-centered design.
Developing channel strategies and mechanisms for managing channel partners to accelerate multi-country implementation.
Utilizing financial planning and analysis and other simulation tools to understand cost-drivers and throughput barriers.
Evaluating and implementing distributed manufacturing models for cost reduction and accelerated scale.
In The Field
Some might call them “clients.” We call them change makers.
Medicines for All Institute
Stop TB Partnership
